AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
2004 MAR 3 - (NewsRx.com & NewsRx.net) -- A researcher has reviewed the prevention of cervical cancer through human papillomavirus (HPV) vaccination in a recent issue of Nature Reviews Immunology.
According to recent research from Australia, "A subset of human papillomaviruses (HPVs) promote anogenital malignancy, including cervical cancer, and prevention and treatment strategies that reflect the causal role of HPV are being developed. Vaccines based on HPV virus-like particles induce genotype-specific virus-neutralizing antibody and prevent infection with HPV1. Persistent papillomavirus infection is required for the development of papillomavirus-associated cancer and, therefore, therapeutic vaccines are being developed to eliminate established papillomavirus infection."
"Such vaccines test principles for the growing field of tumor-antigen-specific immunotherapy," said Ian H. Frazer at the University of Queensland. "This article reviews progress in the field and draws conclusions for the development of ...
Source: HighBeam Research, Prevention of cervical cancer through HPV vaccination reviewed.